Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dolutegravir Open Label Protocol for HIV Infected, Adult and Adolescent Patients With Integrase Resistance

NCT01536873 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT01536873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01536873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dolutegravir Open Label Protocol for HIV Infected, Adult and Adolescent Patients With Integrase Resistance
Lead sponsor
ViiV Healthcare
Phase
Not applicable
Overall status
Completed
Start date
June 14, 2012
Completion date
September 23, 2016
Enrollment
200 (estimated)
Sites
74

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, infection, human immunodeficiency virus